Patient Monitoring Devices Market by Product (Hemodynamic, Neuromonitoring, Cardiac, Fetal & Neonatal, Respiratory, Multiparameter, Remote Patient, Weight, Temperature, and Urine Output Monitoring Devices), and End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- ALL2963662
- 267 Pages
- March 2019
- Medical Devices
The report analyzes the patient monitoring devices market based on three segments, namely, product type, end user, and region. On the basis of product type, it is divided into nine segments—hemodynamic, neuromonitoring, cardiac, fetal & neonatal, respiratory, multiparameter, remote patient, weight, and temperature monitoring devices. Hemodynamic monitoring devices can be further segmented into blood glucose, cholesterol, blood gas & electrolyte analyzer, and blood pressure monitors. Neuromonitoring devices is further categorized into electroencephalograph devices, magnetoencephalography devices, intracranial pressure monitors, transcranial dopplers, and cerebral oximeters. Cardiac monitoring devices are further divided into electrocardiogram devices, Holter monitors, event monitors, and others (implantable loop recorders, cardiac output monitoring devices, and others). Fetal & neonatal monitoring devices are further categorized into ultrasound fetal doppler, internal fetal monitor, and intrauterine pressure catheters. Respiratory monitoring devices are further segmented into capnograph, spirometer, sleep apnea monitor, and pulse oximeter. Multiparameter monitoring devices are further categorized into high, mid, and low acuity. Based on end user, the market is categorized into three segments—hospitals & clinics, home settings, and ambulatory surgical centers. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The global patient monitoring devices market is driven by increase in the geriatric population, growth in the prevalence of patients suffering from different lifestyle diseases, and rise in the adoption rate of remote patient monitoring devices. However, the cost associated with this technology and issues related to government regulations & reimbursements are expected to hamper the global market growth. With the advancements in wireless technology, these devices are used to remotely monitor the physiological parameters of the patients, such as blood glucose level, blood pressure, heart rate, and provide appropriate treatment to the patients.
The growth in competition has led to collaborations and product launches by key players in the patient monitoring devices market. Moreover, Nihon Kohden announced the launch of the advanced bedside monitor called BSM-3500. These monitors are designed to meet the needs of ambulatory surgery and specialty centers. BSM-3500 monitors help provide a range of standard monitoring facilities and many critical capabilities in low acuity settings.
KEY MARKET BENEFITS
• The global patient monitoring devices market report provides an extensive analysis of the current market trends and future estimations in the market.
• The market scenario is comprehensively analyzed with respect to the product and end users.
• The market estimations are based on high-end analysis of the key developments.
• Recent developments and key manufacturers are listed to understand the competitive market scenario.
• In-depth analysis based on region provides an understanding of the regional market, which assists in strategic business planning.
KEY PLAYERS PROFILED
• Medtronic, Inc.
• Biotronik
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Ltd.
• Masimo Corporation
• Nihon Kohden Corporation
• Johnson and Johnson
• Omron Healthcare Co. Ltd.
• Abbott Laboratories
• Koninklijke Philips N.V.
KEY MARKET SEGMENTS
By Product Type
• Hemodynamic Monitoring Devices
o Blood Glucose
o Cholesterol
o Blood Gas & Electrolyte Analyzers/Monitors
o Blood Pressure
• Neuromonitoring Devices
o Electroencephalograph (EEG) Devices
o Magnetoencephalograph (MEG) Devices
o Intracranial Pressure Monitors (ICP)
o Transcranial Dopplers (TCD)
o Cerebral Oximeters
• Cardiac Monitoring Devices
o Electrocardiogram (ECG) Devices
o Implantable Loop Recorders (ILR)
o Cardiac Output Monitoring (COM) Devices
o Event Monitors
• Fetal & Neonatal Monitoring Devices
o Ultrasound Fetal Dopplers
o Internal Fetal Monitors
• Respiratory Monitoring Devices
o Capnographs
o Anesthesia Monitors
o Spirometers
o Pulse Oximeters
o Sleep Apnea Monitoring Devices
• Multiparameter Monitoring Devices
o High Acuity
o Mid Acuity
o Low Acuity
• Remote Patient Monitoring Devices
• Weight Monitoring Devices
• Temperature Monitoring Devices
By End User
• Hospitals & Clinics
• Home Settings
• Ambulatory Surgical Centers (ASC)
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Spain
o Italy
o Russia
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Turkey
o Venezuela
o Republic of South Africa
o Saudi Arabia
o Rest of LAMEA
The other players of the catheters market include (companies not profiled in the report):
• Honeywell International Inc.
• Siemens Healthcare
• Lifewatch AG
• Care Innovations, LLC.
• St. Jude Medical, Inc.
• Smiths Medical
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Government regulations
3.3.1. U.S. FDA
3.3.2. Europe CE mark
3.3.3. Ministry of Health, Labor, and Welfare (MHLW)
3.4. Reimbursement scenarios
3.5. Clinical trials
3.6. Patent analysis
3.6.1. U.S. patent analysis, by market participant
3.6.2. Europe patent analysis, by market participant
3.6.3. China patent analysis, by market participant
3.6.4. Canada patent analysis, by market participant
3.6.5. Japan patent analysis by market participant
3.6.6. Other countries patent analysis, by market participant
3.7. Top impacting factors
3.8. Market Dynamics
3.8.1. Drivers
3.8.1.1. Rise in the prevalence of lifestyle diseases
3.8.1.2. Increase in the geriatric population
3.8.1.3. Rise in the adoption rate of remote patient monitoring devices
3.8.2. Restrains
3.8.2.1. Government regulations and reimbursement issues
3.8.2.2. Limited awareness and high costs
3.8.3. Opportunities
3.8.3.1. Untapped markets in developing countries
3.8.3.2. Technological advancements
Chapter: 4: PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Hemodynamic monitoring devices
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Blood glucose monitors
4.2.4.1. Market size and forecast
4.2.5. Blood gas and electrolyte analyzers/monitors
4.2.5.1. Market size and forecast
4.2.6. Blood pressure monitors
4.2.6.1. Market size and forecast
4.3. Neuromonitoring devices
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Electroencephalograph (EEG) devices
4.3.4.1. Market size and forecast
4.3.5. Transcranial dopplers (TCD)
4.3.5.1. Market size and forecast
4.3.6. Magnetoencephalograph (MEG) devices
4.3.6.1. Market size and forecast
4.3.7. Intracranial pressure monitors (ICP)
4.3.7.1. Market size and forecast
4.3.8. Cerebral oximeters
4.3.8.1. Market size and forecast
4.4. Cardiac monitoring devices
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Electrocardiogram (ECG) devices
4.4.4.1. By type
4.4.4.2. By lead type
4.4.4.3. Market size and forecast
4.4.5. Holter monitors
4.4.5.1. Market size and forecast
4.4.6. Event monitors
4.4.6.1. By type
4.4.6.2. By technology
4.4.6.3. Market size and forecast
4.4.7. Others (Implantable loop recorder, Cardiac output monitor and others)
4.4.7.1. Market size and forecast
4.5. Fetal and neonatal monitoring devices
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Ultrasound
4.5.4.1. Market size and forecast
4.5.5. Electronic Fetal Monitoring Devices
4.5.5.1. Market size and forecast
4.5.6. Fetal Doppler Monitoring Devices
4.5.6.1. Market size and forecast
4.5.7. Other Fetal and Neonatal Monitoring Devices
4.5.7.1. Market size and forecast
4.6. Respiratory monitors
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Capnographs
4.6.4.1. Market size and forecast
4.6.5. Pulse oximeters
4.6.5.1. Market size and forecast
4.6.6. Sleep apnea monitors
4.6.6.1. Market size and forecast
4.6.7. Spirometers
4.6.7.1. Market size and forecast
4.7. Multiparameter monitoring devices
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. High acuity
4.7.4.1. Market size and forecast
4.7.5. Mid acuity
4.7.5.1. Market size and forecast
4.7.6. Low acuity
4.7.6.1. Market size and forecast
4.8. Remote patient monitoring devices
4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast
4.9. Weight monitoring devices
4.9.1. Key market trends
4.9.2. Key growth factors and opportunities
4.9.3. Market size and forecast
4.10. Temperature monitoring devices
4.10.1. Key market trends
4.10.2. Key growth factors and opportunities
4.10.3. Market size and forecast
4.11. Urine output monitoring
4.11.1. Key market trends
4.11.2. Key growth factors and opportunities
4.11.3. Market size and forecast
Chapter: 5: PATIENT MONITORING DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast
5.3. Home settings
5.3.1. Market size and forecast
5.4. Ambulatory surgical centers (ASC)
5.4.1. Market size and forecast
Chapter: 6: PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Market size and forecast
6.2.1.1. U.S. market size and forecast
6.2.1.2. Canada market size and forecast
6.2.1.3. Mexico market size and forecast
6.3. Europe
6.3.1. Market size and forecast
6.3.1.1. Germany market size and forecast
6.3.1.2. France market size and forecast
6.3.1.3. UK market size and forecast
6.3.1.4. Italy market size and forecast
6.3.1.5. Spain market size and forecast
6.3.1.6. Rest of Europe market size and forecast
6.4. Asia-Pacific
6.4.1. Market size and forecast
6.4.1.1. Japan market size and forecast
6.4.1.2. China market size and forecast
6.4.1.3. Australia market size and forecast
6.4.1.4. India market size and forecast
6.4.1.5. South Korea market size and forecast
6.4.1.6. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Market size and forecast
6.5.1.1. Brazil market size and forecast
6.5.1.2. Turkey market size and forecast
6.5.1.3. Venezuela market size and forecast
6.5.1.4. Saudi Arabia market size and forecast
6.5.1.5. Rest of LAMEA market size and forecast
Chapter: 7: COMPANY PROFILES
7.1. Abbott Laboratories
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Biotronik SE & Co. KG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. General Electric Company (GE Healthcare)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. F. Hoffmann-La Roche Ltd.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Johnson & Johnson
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Koninklijke Philips N.V. (Philips Healthcare)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. Masimo Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Product portfolio
7.7.4. Business performance
7.7.5. Key Strategic Moves:
7.8. Medtronic Plc. (Covidien Ltd.)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Nihon Kohden Corporation
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Omron Corporation
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key Strategic Moves:
TABLE 01. CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013–2016
TABLE 02. PATENTS REGISTERED/APPROVED IN THE WORLD 2010-2016
TABLE 03. U.S. PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010- 2016
TABLE 04. EUROPE PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 05. CHINA PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 06. CANADA PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 07. JAPAN PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 08. OTHERS PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016
TABLE 09. GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 10. HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 11. HEMODYNAMIC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 12. BLOOD GLUCOSE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 13. BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 14. BLOOD PRESSURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 15. NEUROMONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 16. NEUROMONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 17. ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 18. TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 19. MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 20. INTRACRANIAL PRESSURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 21. CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 22. CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 23. CARDIAC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 24. ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 25. HOLTER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 26. EVENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 27. OTHER CARDIAC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 28. FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 29. FETAL AND NEONATAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 30. ULTRASOUND MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 31. ELECTRONIC FETAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 32. FETAL DOPPLER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 33. OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 34. RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 35. RESPIRATORY MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 36. CAPNOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 37. PULSE OXIMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 38. SLEEP APNEA MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 39. SPIROMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 40. MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 41. MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 42. HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 43. MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 44. LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 45. REMOTE PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 46. WEIGHT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 47. TEMPERATURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 48. PATIENT MONITORING DEVICES MARKET FOR URINE MONITORING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 49. GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USERS, 2017–2025 ($MILLION)
TABLE 50. PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 51. PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 52. PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 53. PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2017–2025 ($MILLION)
TABLE 54. NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55. NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 56. NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 57. EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 58. EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 59. EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 60. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 61. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 62. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 63. LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64. LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 65. LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 66. ABBOTT: COMPANY SNAPSHOT
TABLE 67. ABBOTT: OPERATING SEGMENTS
TABLE 68. ABBOTT: PRODUCT PORTFOLIO
TABLE 69. BIOTRONIK: COMPANY SNAPSHOT
TABLE 70. BIOTRONIK: OPERATING SEGMENTS
TABLE 71. BIOTRONIK: PRODUCT PORTFOLIO
TABLE 72. GE: COMPANY SNAPSHOT
TABLE 73. GE: OPERATING SEGMENTS
TABLE 74. GE: PRODUCT PORTFOLIO
TABLE 75. ROCHE: COMPANY SNAPSHOT
TABLE 76. ROCHE: OPERATING SEGMENTS
TABLE 77. ROCHE: PRODUCT PORTFOLIO
TABLE 78. J&J: COMPANY SNAPSHOT
TABLE 79. J&J: OPERATING SEGMENTS
TABLE 80. J&J: PRODUCT PORTFOLIO
TABLE 81. PHILIPS: COMPANY SNAPSHOT
TABLE 82. PHILIPS: OPERATING SEGMENTS
TABLE 83. PHILIPS: PRODUCT PORTFOLIO
TABLE 84. MASIMO: COMPANY SNAPSHOT
TABLE 85. MASIMO: PRODUCT PORTFOLIO
TABLE 86. MEDTRONIC: COMPANY SNAPSHOT
TABLE 87. MEDTRONIC: OPERATING SEGMENTS
TABLE 88. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 89. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 90. GSK: PRODUCT PORTFOLIO
TABLE 91. OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 92. OMRON CORPORATION: OPERATING SEGMENTS
TABLE 93. OMRON CORPORATION: PRODUCT PORTFOLIO
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
